Adage Capital Partners
NXTM

Adage Capital Partners’s NxStage Medical Inc. NXTM Stock Holding History

Adage Capital Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300,000
Closed -$7.27M – 789
2017
Q4 		$7.27M Buy
300,000
+150,000
+100% +$3.95M 0.02% 602
2017
Q3 		$4.14M Buy
+150,000
New +$4M 0.01% 640
2014
Q3 		– Sell
-200,000
Closed -$2.87M – 771
2014
Q2 		$2.87M Buy
200,000
+150,000
+300% +$1.96M 0.01% 642
2014
Q1 		$637K Buy
+50,000
New +$652K ﹤0.01% 662

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners's NXTM Position: Q1 2018 in Review

Adage Capital Partners sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 300,000 shares — an estimated $7.27M sold.

Adage Capital Partners first reported a position in NXTM in Q1 2014 and held it in 4 quarters. The position peaked at $7.27M in Q4 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • Adage Capital Partners reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 NxStage Medical Inc. shares in Q1 2018, an estimated $7.27M.
  • Adage Capital Partners first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 4 quarters.
  • Adage Capital Partners's NxStage Medical Inc. position peaked at $7.27M in Q4 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Adage Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.